BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 8644896)

  • 21. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea.
    al-Yaman F; Genton B; Falk M; Anders RF; Lewis D; Hii J; Beck HP; Alpers MP
    Am J Trop Med Hyg; 1995 Jan; 52(1):66-71. PubMed ID: 7856827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in the relationship between anti-MSP-1(19) antibody response and age in children infected with Plasmodium falciparum during the dry and rainy seasons.
    Omosun YO; Anumudu CI; Adoro S; Odaibo AB; Sodeinde O; Holder AA; Nwagwu M; Nwuba RI
    Acta Trop; 2005 Sep; 95(3):233-47. PubMed ID: 16055071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.
    Okech BA; Corran PH; Todd J; Joynson-Hicks A; Uthaipibull C; Egwang TG; Holder AA; Riley EM
    Infect Immun; 2004 Mar; 72(3):1557-67. PubMed ID: 14977962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
    Ramasamy R; Nagendran K; Ramasamy MS
    Am J Trop Med Hyg; 1994 May; 50(5):537-47. PubMed ID: 7515593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.
    Riley EM; Allen SJ; Wheeler JG; Blackman MJ; Bennett S; Takacs B; Schönfeld HJ; Holder AA; Greenwood BM
    Parasite Immunol; 1992 May; 14(3):321-37. PubMed ID: 1625908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-dependent antibody response to Plasmodium falciparum merozoite surface protein 2 (MSP-2).
    Khosravi A; Hommel M; Sayemiri K
    Parasite Immunol; 2011 Mar; 33(3):145-57. PubMed ID: 21306398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitopes in the 19kDa fragment of the Plasmodium falciparum major merozoite surface protein-1 (PfMSP-1(19)) recognized by human antibodies.
    Shai S; Blackman MJ; Holder AA
    Parasite Immunol; 1995 May; 17(5):269-75. PubMed ID: 7545808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
    Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P
    Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam.
    Wang L; Richie TL; Stowers A; Nhan DH; Coppel RL
    Infect Immun; 2001 Jul; 69(7):4390-7. PubMed ID: 11401978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.
    Zhou Z; Xiao L; Branch OH; Kariuki S; Nahlen BL; Lal AA
    Am J Trop Med Hyg; 2002 Jan; 66(1):7-12. PubMed ID: 12135271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.
    Cavanagh DR; Dodoo D; Hviid L; Kurtzhals JA; Theander TG; Akanmori BD; Polley S; Conway DJ; Koram K; McBride JS
    Infect Immun; 2004 Nov; 72(11):6492-502. PubMed ID: 15501780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.
    Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG
    Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children.
    Irani V; Ramsland PA; Guy AJ; Siba PM; Mueller I; Richards JS; Beeson JG
    Clin Infect Dis; 2015 Oct; 61(8):1244-52. PubMed ID: 26136391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
    Osier FH; Fegan G; Polley SD; Murungi L; Verra F; Tetteh KK; Lowe B; Mwangi T; Bull PC; Thomas AW; Cavanagh DR; McBride JS; Lanar DE; Mackinnon MJ; Conway DJ; Marsh K
    Infect Immun; 2008 May; 76(5):2240-8. PubMed ID: 18316390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
    Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
    Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.
    Riley EM; Morris-Jones S; Blackman MJ; Greenwood BM; Holder AA
    Parasite Immunol; 1993 Sep; 15(9):513-24. PubMed ID: 7877849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians.
    Scopel KK; da Silva-Nunes M; Malafronte RS; Braga EM; Ferreira MU
    Am J Trop Med Hyg; 2007 Jun; 76(6):1084-91. PubMed ID: 17556615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to the major merozoite surface coat protein of Plasmodium falciparum (gp195) in a human population living in a malaria-endemic area of the Philippines.
    Kramer KJ; Oberst R
    Am J Trop Med Hyg; 1992 Oct; 47(4):429-39. PubMed ID: 1443339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
    McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC
    Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.